Tang Capital Management »

Boundless Bio shares owned by Tang Capital Management

Quarter-by-quarter ownership of Boundless Bio (BOLD) shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Boundless Bio

Tip: Access up to 7 years of quarterly data

All positions including Boundless Bio held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boundless Bio by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $6.4M 2.6M 2.50

More positions owned by Tang Capital Management

Aurinia Pharmaceuticals (AUPH)
Spyre Therapeutics Com New (SYRE)
Mirum Pharmaceuticals (MIRM)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Celcuity (CELC)
Corcept Therapeutics Incorporated (CORT)
Ptc Therapeutics I (PTCT)
Lakefront Biotherapeutics Nv Spon Adr
Capricor Therapeutics Com New (CAPR)
Tarsus Pharmaceuticals (TARS)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Anaptysbio Inc Common (ANAB)
Immunocore Hldgs Ads (IMCR)
Compass Pathways Sponsored Ads (CMPS)
Biosante Pharmaceuticals (ANIP)

View all positions for Tang Capital Management

Top funds holding Boundless Bio

FMR
Arch Venture Corp
Tang Capital Management
ADAR1 Capital Management
Sectoral Asset Management
Vanguard Capital Management
Wellington Management Company
Renaissance Technologies
Alyeska Investment Group
Affinity Asset Advisors
Rbf Capital
Ensign Peak Advisors
Sio Capital Management
Stonepine Capital Management
Citadel Advisors

View all funds holding Boundless Bio